HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sho-Ichi Yamagishi Selected Research

Anemia

9/2017Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-Anemia.
1/2016Serum Levels of Growth Differentiation Factor 11 Are Independently Associated with Low Hemoglobin Values in Hemodialysis Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sho-Ichi Yamagishi Research Topics

Disease

24Cardiovascular Diseases (Cardiovascular Disease)
10/2023 - 06/2007
15Diabetic Retinopathy (Retinopathy, Diabetic)
01/2018 - 04/2002
14Atherosclerosis
03/2023 - 06/2005
14Diabetic Nephropathies (Diabetic Nephropathy)
01/2021 - 01/2008
13Type 2 Diabetes Mellitus (MODY)
10/2023 - 01/2009
12Inflammation (Inflammations)
08/2023 - 10/2011
12Insulin Resistance
01/2021 - 12/2006
11Neoplasms (Cancer)
08/2021 - 04/2004
9Fibrosis (Cirrhosis)
11/2023 - 02/2003
9Body Weight (Weight, Body)
01/2022 - 12/2006
9Diabetic Angiopathies (Diabetic Angiopathy)
10/2016 - 01/2004
7Chronic Renal Insufficiency
10/2020 - 06/2007
6Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2023 - 07/2007
6Melanoma (Melanoma, Malignant)
01/2021 - 04/2004
6Albuminuria
10/2020 - 01/2014
6Hyperglycemia
07/2020 - 07/2007
5Atherosclerotic Plaque (Atheroma)
03/2023 - 10/2011
5Neoplasm Metastasis (Metastasis)
01/2021 - 04/2015
5Diabetes Complications
01/2018 - 01/2004
5Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2014 - 05/2005
4Essential Hypertension
08/2023 - 11/2005
4Chronic Kidney Failure (Chronic Renal Failure)
09/2017 - 10/2006
3Glucose Intolerance
01/2020 - 10/2011
3Alzheimer Disease (Alzheimer's Disease)
01/2018 - 09/2004
3Uveitis
12/2014 - 02/2007
2Insulinoma
07/2023 - 11/2022
2Diabetic Neuropathies (Diabetic Neuropathy)
03/2023 - 10/2016
2Cardiomegaly (Heart Hypertrophy)
05/2022 - 03/2021
2Frailty
12/2021 - 10/2020
2Dyslipidemias (Dyslipidemia)
07/2020 - 01/2010
2Hypertension (High Blood Pressure)
07/2020 - 08/2007
2Obesity
02/2020 - 12/2016

Drug/Important Bio-Agent (IBA)

56Advanced Glycation End ProductsIBA
03/2023 - 02/2003
28pigment epithelium-derived factorIBA
08/2021 - 04/2004
16Proteins (Proteins, Gene)FDA Link
05/2022 - 04/2004
15Glucose (Dextrose)FDA LinkGeneric
10/2023 - 05/2005
10Receptor for Advanced Glycation End ProductsIBA
03/2023 - 11/2005
8Biomarkers (Surrogate Marker)IBA
05/2022 - 07/2010
8GlyceraldehydeIBA
12/2021 - 09/2004
8Nucleotide AptamersIBA
01/2021 - 01/2015
8N,N-dimethylarginine (asymmetric dimethylarginine)IBA
09/2017 - 06/2007
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2021 - 04/2004
7Insulin (Novolin)FDA Link
01/2020 - 12/2006
6NADPH Oxidases (NAD(P)H oxidase)IBA
08/2021 - 06/2005
6Blood Glucose (Blood Sugar)IBA
01/2021 - 03/2010
5Hemoglobins (Hemoglobin)IBA
03/2020 - 10/2011
5HDL CholesterolIBA
01/2020 - 05/2005
5Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2020 - 06/2007
5Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2014 - 06/2007
5Triglycerides (Triacylglycerol)IBA
02/2012 - 05/2005
5Angiotensin IIIBA
08/2007 - 06/2005
4CreatinineIBA
01/2021 - 02/2012
4Sodium-Glucose Transport ProteinsIBA
10/2020 - 11/2016
4CholesterolIBA
07/2020 - 01/2010
4Uric Acid (Urate)IBA
01/2019 - 06/2006
4Telmisartan (Micardis)FDA Link
05/2016 - 11/2005
4Retinaldehyde (Retinal)IBA
09/2014 - 01/2005
3LipidsIBA
01/2024 - 01/2010
3ApolipoproteinsIBA
01/2024 - 05/2020
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2023 - 01/2010
3LDL CholesterolIBA
12/2023 - 01/2010
3olmesartanIBA
08/2023 - 09/2011
3Angiotensin II Type 1 Receptor BlockersIBA
08/2023 - 12/2006
3Antihypertensive Agents (Antihypertensives)IBA
08/2023 - 01/2016
3LigandsIBA
03/2023 - 01/2004
3EnzymesIBA
11/2022 - 05/2005
3Messenger RNA (mRNA)IBA
05/2022 - 01/2004
3pentosidineIBA
12/2021 - 09/2011
3Dipeptidyl-Peptidase IV InhibitorsIBA
09/2021 - 02/2020
3Glucagon (Glukagon)FDA Link
01/2021 - 12/2019
3AlbuminsIBA
03/2020 - 04/2009
3Hypoglycemic Agents (Hypoglycemics)IBA
02/2020 - 10/2011
3SugarsIBA
10/2018 - 01/2008
3DNA (Deoxyribonucleic Acid)IBA
01/2018 - 11/2013
3Cell Surface ReceptorsIBA
01/2018 - 01/2004
3sulforaphaneIBA
01/2018 - 09/2014
3Nitric Oxide Synthase (NO Synthase)IBA
02/2014 - 04/2009
2Glucagon-Like Peptide-1 Receptor AgonistsIBA
10/2023 - 02/2020
2Amlodipine (Norvasc)FDA LinkGeneric
08/2023 - 01/2023
2Calcium Channel Blockers (Blockers, Calcium Channel)IBA
08/2023 - 01/2023
2AntibodiesIBA
07/2023 - 01/2018
2Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
07/2023 - 11/2022
2Zinc Transporter 8IBA
07/2023 - 11/2022
2C-PeptideIBA
07/2023 - 01/2021
2AutoantibodiesIBA
07/2023 - 11/2022
2Apolipoproteins E (ApoE)IBA
03/2023 - 05/2020
2oxidized low density lipoproteinIBA
03/2023 - 07/2020
2ImmunosorbentsIBA
11/2022 - 12/2021
21,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA
05/2022 - 10/2019
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2022 - 01/2008
2SodiumIBA
01/2022 - 02/2018
2Peptides (Polypeptides)IBA
03/2021 - 02/2014
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 12/2011
2Sodium-Glucose Transporter 2 InhibitorsIBA
01/2021 - 10/2019
2HMGB1 Protein (HMG1)IBA
01/2021 - 12/2011
2Streptozocin (Streptozotocin)FDA Link
07/2020 - 01/2017
2FructoseIBA
01/2020 - 12/2016

Therapy/Procedure

10Therapeutics
12/2023 - 07/2007
6Renal Dialysis (Hemodialysis)
01/2016 - 01/2008
2Oral Administration
01/2020 - 12/2014